Mirum Pharmaceuticals, Inc. (MIRM) M&A Call Transcript
Source: SeekingAlpha
2025-12-08 16:17:18 ET
Mirum Pharmaceuticals, Inc. (MIRM) M&A Call December 8, 2025 8:30 AM EST
Company Participants
Meredith Kiernan
Christopher Peetz - CEO & Director
Joanne M. Quan - Chief Medical Officer
Peter Radovich - COO & President
Eric Bjerkholt - Chief Financial Officer
...
Read the full article on Seeking Alpha
For further details see:
Mirum Pharmaceuticals, Inc. (MIRM) M&A Call Transcript
Mirum Pharmaceuticals Inc.
NASDAQ: MIRM
MIRM Trading
0.46% G/L:
$90.25 Last:
202,111 Volume:
$90.13 Open:
MIRM Latest News
March 05, 2026 08:00:00 am
Mirum Pharmaceuticals Provides AZURE Clinical Program Update for brelovitug in Chronic Hepatitis Delta Virus
MIRM Stock Data
$5,184,583,745
44,013,457
0.43%
119
N/A
Biotechnology & Life Sciences
Healthcare
US
Foster City
